﻿<?xml version="1.0" encoding="UTF-8"?>
<!--RSS generated by Windows SharePoint Services V3 RSS Generator on 5/18/2013 9:19:13 AM-->
<?xml-stylesheet type="text/xsl" href="/_layouts/RssXslt.aspx?List=853f6735-9cb2-4a5a-a363-ef2d334f1001" version="1.0"?>
<rss version="2.0">
  <channel>
    <title>Shire Australia: shire-australia</title>
    <link>http://www.shireaustralia.com.au/shire-australia/Forms/AllItems.aspx</link>
    <description>RSS feed for the shire-australia list.</description>
    <lastBuildDate>Sat, 18 May 2013 08:19:13 GMT</lastBuildDate>
    <generator>Windows SharePoint Services V3 RSS Generator</generator>
    <ttl>60</ttl>
    <image>
      <title>Shire Australia: shire-australia</title>
      <url>/_layouts/images/homepage.gif</url>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/AllItems.aspx</link>
    </image>
    <item>
      <title>hereditary-angioedema</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=17</link>
      <description><![CDATA[<div><b>Page Title:</b> Hereditary Angioedema :: Firazyr</div>
]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:53 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=17</guid>
    </item>
    <item>
      <title>in-the-community</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=2</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Shire Australia in the community</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:58 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=2</guid>
    </item>
    <item>
      <title>In-the-Community_</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=16</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:59 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=16</guid>
    </item>
    <item>
      <title>lysosomal-storage-disorders</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=7</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Fabry Disease :: Replagal</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:59 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=7</guid>
    </item>
    <item>
      <title>our-social-responsibility</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=27</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:54 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=27</guid>
    </item>
    <item>
      <title>privacy</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=30</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Privacy Statement</div>
]]></description>
      <author>Brock Hardman</author>
      <pubDate>Thu, 27 Sep 2012 19:52:02 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=30</guid>
    </item>
    <item>
      <title>products</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=19</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:54 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=19</guid>
    </item>
    <item>
      <title>shire-global</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=10</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Shire Global</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:59 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=10</guid>
    </item>
    <item>
      <title>supporting-our-local-community-in-australia</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=23</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:54 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=23</guid>
    </item>
    <item>
      <title>terms-of-use</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=12</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Terms of Use</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:59 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=12</guid>
    </item>
    <item>
      <title>therapeutic-areas</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=4</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Therapeutic Areas </div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:05:00 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=4</guid>
    </item>
    <item>
      <title>working-with-health-consumer-organisations</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=29</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:55 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=29</guid>
    </item>
    <item>
      <title>about-shire-australia</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=1</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> About Shire Australia</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:58 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=1</guid>
    </item>
    <item>
      <title>careers-at-shire</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=14</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Careers at Shire</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:58 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=14</guid>
    </item>
    <item>
      <title>chronic-kidney-disease</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=18</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Chronic Kidney Disease :: Fosrenol</div>
]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:52 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=18</guid>
    </item>
    <item>
      <title>consumer</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=20</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:52 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=20</guid>
    </item>
    <item>
      <title>contact-us</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=3</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Contact Us</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:58 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=3</guid>
    </item>
    <item>
      <title>disclaimer</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=11</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Disclaimer</div>
]]></description>
      <author>Kyle McBride</author>
      <pubDate>Mon, 12 Jul 2010 16:04:58 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=11</guid>
    </item>
    <item>
      <title>essential-thrombocythaemia</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=22</link>
      <description><![CDATA[<div><b>Meta Keywords:</b> Shire Australia, chronic kidney disease, fabry disease, essential thrombocythaemia, hyperphosphataemia, hereditary angioedema, hyperphosphataemia, biopharmaceutical, Replagal, Fosrenol, Agrylin</div>
<div><b>Page Title:</b> Essential Thrombocythaemia :: Agrylin</div>
]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:53 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=22</guid>
    </item>
    <item>
      <title>gastrointestinal-disease</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=24</link>
      <description><![CDATA[<div><b>Page Title:</b> Gastrointestinal Disease :: Mezavant</div>
]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:53 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=24</guid>
    </item>
    <item>
      <title>hco-disclosure-list</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=25</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:53 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=25</guid>
    </item>
    <item>
      <title>healthcare-professional</title>
      <link>http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=21</link>
      <description><![CDATA[]]></description>
      <author>Ricky Vasquez</author>
      <pubDate>Wed, 04 Jan 2012 23:06:53 GMT</pubDate>
      <guid isPermaLink="true">http://www.shireaustralia.com.au/shire-australia/Forms/DispForm.aspx?ID=21</guid>
    </item>
  </channel>
</rss>